FIELD: medicine, pharmacy.
SUBSTANCE: invention refers to pharmaceutical industry and represents application of diamineoxydase to produce a pharmaceutical composition for treatment of diseases or pathologic conditions selected from the group consisting of migraine, fibromyalgia, spondylitis, and muscle contractures, characterized by local application of the composition.
EFFECT: invention provides expansion of the arsenal for migraine, fibromyalgia, spondylitis and muscular contractures treatment.
12 cl, 6 tbl, 7 ex
Authors
Dates
2017-04-13—Published
2012-03-15—Filed